MGTA-456

· Masonic Cancer Center, University of Minnesota

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MGTA-456, covering 2021-10-28 to 2024-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy [Phase 2]